← Open Payments lookup

MARCO MARTINEZ: Open Payments

NPI 1922542182 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$893 in 34 payments from 13 companies in 2025. Trend: 2023 $784 · 2024 $1,352 · 2025 $893

Food & beverage: $893
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$238
GlaxoSmithKline, LLC.7$150
Lilly USA, LLC5$111
Boehringer Ingelheim Pharmaceuticals, Inc.3$87
ABBVIE INC.3$80
Novo Nordisk Inc3$75
Philips North America LLC1$27
Kowa Pharmaceuticals America, Inc.1$24
Seqirus USA Inc1$24
Otsuka America Pharmaceutical, Inc.1$23

Products named: FARXIGA, TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, AIRSUPRA, Ozempic, LINZESS, Vest Therapy Und.

Industry payments across CA — which companies pay providers there.